Allergan Inc. said today, June 18th, 2009, that the Food and Drug Administration approved a drug it developed to treat macular edema, a condition that can cause loss of central vision. Irvine-based Allergan says the drug, trade-named Ozurdex, is the first and only drug therapy approved for treating macular edema associated with retinal vein occlusion, the […]